Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Researchers identified 4 prepregnancy conditions that were associated with better pregnancy outcomes among patients with SLE.

Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...

Three Husker students under the mentorship of Luwen Zhang, a leading University of Nebraska-Lincoln virologist, have achieved ...

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

Systemic Lupus Erythematosus (about 70% of cases are systemic); Discoid Lupus Cutaneous, which is limited to the skin; and Drug Induced Lupus, which occurs most commonly with drugs used to treat ...

A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...

Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...

HRT may be safe for people with lupus in certain instances. One 2022 review involving 16 studies found that HRT can help manage menopausal symptoms without the extra risk in most cases. Most studies ...

Masonic Medical Research Institute announced the second annual Lupus Walk, in partnership with Lupus and Allied Diseases Association, will be held on Saturday, May 17, in support of MMRI’s lupus ...

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here. More than half of patients with psoriatic arthritis ...